Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Jubilant Pharmova Ltd

JUBLPHARMA.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Small Cap Analyst: BUY

Last Close

$9.07

▼ -2.77%

Market Cap $1.44B · Vol 221.70K

Key Metrics

P/E Ratio

39.05

FWD: 23.69

Market Cap

$1.44B

Small Cap

Div Yield

0.58%

Annual dividend

EPS Growth

+5.11%

YoY

RSI (14)

24.39

Momentum

Beta

1.29

vs Market

52W High

$12.41

32.62% below

52W Low

$8.24

6.75% above

Volume

221.70K

Avg 195.06K

P/B

1.82

Price-to-book

ROE

6.86%

Return on equity

Free Float

38.87%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Jubilant Pharmova Ltd (JUBLPHARMA.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does JUBLPHARMA.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-7.10%

-11.15%

-13.80%

-5.17%

YTD

-19.33%

-18.01%

+74.77%

+33.94%

Financials & Valuation

TTM · Annual

Total Revenue	$885.93M
Net Income	$42.53M
Revenue Growth (YoY)	+17.29%
Gross Margin	56.68%
Operating Margin	9.90%
Net Profit Margin	4.80%
ROE	6.86%
ROA · ROIC	4.34% · 5.37%

P/E Ratio	39.05
Forward P/E (FY1)	23.69
PEG Ratio	-0.62
P/S	1.57
P/B	1.82
P/FCF	N/A
EPS Growth	+5.11%
Outstanding Shares	158.40M

Technical Indicators

50-Day SMA	$10.12
200-Day SMA	$10.28
RSI (14)	24.39
Beta	1.29
52-Week High	$12.41
52-Week Low	$8.24

Volume Today	221.70K
Avg Daily Volume (30D)	195.06K
Relative Volume	1.14x
Volatility (10D)	44.19
Volatility (30D)	34.19
Free Float	38.87%

Analyst Consensus

BUY

Current Price $9.07

Mean Target $12.21

52W Low$8.24 52W High$12.41

Current

Target

$8.24 $12.41

Current Analyst target

+34.63% upside potential · 4 analysts

Identifiers

ExchangeNSE India

FIGIBBG001S851L8

ISININE700A01033

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateOct 28, 2026

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Jubilant Pharmova Limited is an India-based integrated pharmaceutical company. The Company’s segments include Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing Organisation-Sterile Injectables, Generics, Contract Research, Development and Manufacturing Organisation, Proprietary Novel Drugs, and Management Services. The Radiopharma segment comprises radiopharmaceuticals, including radio pharmacies. The Contract Development and Manufacturing Organisation-Sterile Injectables segment includes contract development and manufacturing organisation-sterile injectables products. The Generics segment includes solid dosage formulations. The Contract Research, Development and Manufacturing Organisation segment includes drug discovery services and active pharmaceutical ingredients. The Proprietary Novel Drugs segment includes patient-focused biopharmaceutical businesses working to address unmet medical needs in oncology and autoimmune diseases.